NUC-3373

· NuCana plc

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NUC-3373, covering 2025-04-23 to 2026-07-23. Get the full timeline:

Most recent: Clinical Trial Results: NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours [Phase 1, Phase 2]